Vibgyor Drugs Private Limited, a active private limited company, was established on 20 March 2009 in Kamareddy, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2009PTC063120. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.
It upholds a compliant status. Employing 15 professional, Its leadership includes Venkata Ravindra Koganti (Managing Director), Geetha Sree Koganti (Director). Past directors included Raja Sekhara Rao Narayanam, Ravi Chikkala, Satyendra Kumar Singh. It holds ₹1.20 Cr open charges and ₹4.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sy.No. 306 & 307, Jangampally (V), Opp: Divya Restaurant, Domakonda Service Road, Bhik, Noor (M), Kamareddy, Telangana, 503102.
U24100TG2009PTC063120
063120
20 March 2009
₹5.00 Cr
₹5.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vibgyor Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Ravindra Koganti | Managing Director | 05 Dec 2014 | Current |
| Geetha Sree Koganti | Director | 28 Nov 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 11 Jul 2013 | Past |
| Pramod Abcsdd | Additional Director | 14 Nov 2012 | Past |
| Pramod Abcsdd | Additional Director | 06 Jun 2016 | Past |
| Pramod Abcsdd | Director | 17 Aug 2022 | Past |
| Pramod Abcsdd | Director | 12 Aug 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 26 Aug 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vibgyor Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 215.18% increase. The company also saw a substantial improvement in profitability, with a 159.5% increase in profit. The company's net worth moved up by a moderate rise of 1.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Vibgyor Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,000,000.00
₹49,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Dec 2018 | Syndicate Bank | ₹1.20 Cr | Open |
| 24 Dec 2014 | Syndicate Bank | ₹4.95 Cr | Satisfied |
Explore comprehensive loan charge details -
Vibgyor Drugs has a workforce of 15 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vibgyor Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vibgyor Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vibgyor Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Vibgyor Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity A charge registered on 24 Dec 2014 via Charge ID 10543406 with Syndicate Bank was fully satisfied on 16 Nov 2022. was completed.
A charge with Syndicate Bank amounted to Rs. 1.20 Cr with Charge ID 100232637 was registered on 12 Dec 2018. was recorded as a recent event.
Geetha Sree Koganti was appointed as a Director was appointed as a Director on 28 Nov 2015 & has been associated with this company since 10 years 3 days . was recorded as a recent event.
The activity A charge with Syndicate Bank amounted to Rs. 4.95 Cr with Charge ID 10543406 was registered on 24 Dec 2014. was completed.
The CIN of Vibgyor Drugs Private Limited is U24100TG2009PTC063120.
Vibgyor Drugs Private Limited is headquartered at Sy.No. 306 & 307, Jangampally (V), Opp: Divya Restaurant, Domakonda Service Road, Bhik, Noor (M), Kamareddy, Telangana, 503102.
Vibgyor Drugs Private Limited was incorporated on 20 March 2009.
The current directors of Vibgyor Drugs Private Limited are
The primary industry of Vibgyor Drugs Private Limited is Manufacturing.
Vibgyor Drugs Private Limited is unlisted.
The authorized capital of Vibgyor Drugs Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.
The compliance status of Vibgyor Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX